Skip to main content

EDITORIAL article

Front. Immunol.
Sec. Viral Immunology
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1441199
This article is part of the Research Topic Therapeutic management of COVID-19 in immunocompromised patients and interaction with the immune response: from preventive to curative strategies View all 9 articles

Editorial : management of COVID-19 in immunocompromised patients and interaction with the immune response: from preventive to curative strategies

Provisionally accepted
Ilies Benotmane Ilies Benotmane 1*Morgane Solis Morgane Solis 2
  • 1 Service de Néphrologie, Dialyse et Transplantation, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
  • 2 Laboratoire de Virologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, Alsace, France

The final, formatted version of the article will be published soon.

    Keywords: COVID-19, SARS-CoV- 2, immunocompromidsed patients, Solid organ tranplantation, HIV, Vaccine, Monocloanl antibody

    Received: 30 May 2024; Accepted: 10 Jul 2024.

    Copyright: © 2024 Benotmane and Solis. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Ilies Benotmane, Service de Néphrologie, Dialyse et Transplantation, Hôpitaux Universitaires de Strasbourg, Strasbourg, France

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.